Group 1: 10 ug FMP012 with 2 ug GLA-SE
S-11-21
Phase 1 mab completed
Quick answer
Group 1: 10 ug FMP012 with 2 ug GLA-SE for Malaria is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Malaria
- Phase
- Phase 1
- Modality
- mab
- Status
- completed